Evaluation of the Modulatory Effect of <i>Annona muricata</i> Extracts on the Activity of Some Selected Antibiotics against Biofilm-Forming MRSA

Neglo, David; Tettey, Clement Okraku; Essuman, Edward Ken; Amenu, Justice Dziedzorm; Mills-Robertson, Felix Charles; Sedohia, Daniel; Boakye, Adjoa Agyemang; Abaye, Daniel A.

doi:https://doi.org/10.1155/2021/9342110

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Conflicts of Interest References Copyright Related Articles

Research Article | Open Access

Volume 2021 | Article ID 9342110 | https://doi.org/10.1155/2021/9342110

Evaluation of the Modulatory Effect of Annona muricata Extracts on the Activity of Some Selected Antibiotics against Biofilm-Forming MRSA

David Neglo,^1,2Clement Okraku Tettey,³Edward Ken Essuman,⁴Justice Dziedzorm Amenu,⁵Felix Charles Mills-Robertson,²Daniel Sedohia,⁶Adjoa Agyemang Boakye,³and Daniel A. Abaye¹

Academic Editor: Philip F. Uzor

Received22 Jun 2021

Revised23 Nov 2021

Accepted09 Dec 2021

Published20 Dec 2021

Abstract

The study investigated the influence of Annona muricata extracts on the action of selected antibiotics against biofilm-forming MRSA. The various parts of the plant were processed into powder and extracted with ethanol or hot water and then screened for the presence of phytochemicals. The modulatory effect of the Annona muricata extract was also tested on some antibiotics against Methicillin-resistant Staphylococcus aureus (MRSA). The findings from this study revealed that the various parts of the Annona muricata extract (ethanolic and aqueous) contained different proportions of secondary metabolites. Varied antimicrobial activities were observed when the extract of the A. muricata was exposed to MRSA strain at a concentration of 100 mg/mL. The stem recorded the highest (17.00 and 18.00 mm) inhibitory activity against MRSA for both the aqueous and the ethanolic extract, respectively, and this was not different from the control, tetracycline. Again, the results on the modulatory action indicated that out of the 10 extracts of A. muricata, 4 of them antagonized the activity of ampicillin against the tested MRSA by a factor of 0.5 folds and the rest potentiated the drug within 1–4 folds, respectively. On the other hand, the various test extracts significantly potentiated the efficacy of streptomycin and tetracycline against the MRSA by a range of 1–32 folds with the aqueous root extract recording the highest synergistic effect and ethanol seed extract with the least effect. The findings of this study support the antibacterial activities of the A. muricata plant parts.

1. Introduction

Contemporarily, a notable number of noncommunicable and infectious diseases have become an indispensable headache in many countries, accounting for the majority of the increase of death tolls in most tropical nation states, especially Africa [1, 2]. Undoubtedly, this ever persistence of these deadly illnesses can be attributed to the modern-day problem of drug resistance caused by pathogens in place of unselective use of over-the-counter drugs [3] as well as factors that include failure to complete a prescribed dosage, irrational drug use, prolonged drug use, and therapy duration [4].

In effect, besides the latest discovery of resistance mechanisms through scientific researches such as efflux pump possession, target site diversion, resistance gene acquisition, and others by bacterial species to inactivate the potency of most antibacterial agents [5, 6], bacterial biofilms have also been reported and noted to form 65% of microbial infections, and bacteria living in them develop resistance to antibiotics a thousand times than those existing as planktonic cells, thereby calling for urgent attention [7]. This, therefore, has made the treatment of infections difficult, whereas surgical and other medical procedures have also been contemporarily associated with high-risk interventions causing prolonged sickness, disability, and death [8]. Consequently, the capacity to use phytochemicals to modulate the activities of commercial antimicrobials to overcome resistance from pathogens has developed through research [4, 9]. Hence, research is being carried out in recent times into the synergism of conventional antibiotics to establish and develop new drugs to tackle the antimicrobial resistance menace.

A. muricata is commonly known as soursop and one of the most important traditional medicinal plants which contain a lot of chemicals that exhibit various pharmacological properties [10]. It has since been adopted in traditional medicine to treat varied diseased conditions ranging from fever to diabetes and cancer. Over 200 bioactive compounds have been secluded from this plant, some of which are alkaloids, phenols, and acetogenins [11]. This plant is extensively disseminated in the tropical regions of Central and South America, Western Africa, Central and Eastern Africa, and Southeast Asia [11].

Recent work on the phytochemistry of A. muricata extracts has proven as a potent antioxidant, antimicrobial, anti-inflammatory, insecticidal, larvicidal, and cytotoxic against cancer cells. Other studies have also proven them as anxiolytic, antistress, anti-inflammatory, immunomodulatory, antimalarial, antidepressant, gastroprotective, wound healing, hepatoprotective, hypoglycemic, anticancer, and antitumoral agents [12, 13]. The commonest use of its preparations in traditional medicine is the hot water preparation of the bark, root, seed, or leaves. Moreover, recorded in the Brazilian Amazon, the leaves of the plant are used to treat liver problems, and the extracted leaf oil has been proven to help cure rheumatism, neuralgia, and arthritis. It is worth noting that some tropical sub-Saharan countries involving Uganda have been testified to employ all parts of this plant to treat malaria, stomachache, parasitic infections, diabetes, and cancer [14]. Its fruit juice has been used to cure diarrhoea, heart, and liver diseases [12, 15], and it is effective against intestinal pathogens in South America. This study intended to explore the influence of Annona muricata extracts on the actions of selected antibiotics against biofilm-forming Methicillin-resistant Staphylococcus aureus (MRSA).

2. Materials and Methods

2.1. Source of Samples, Identification, and Preparation

The selected parts of Annona muricata, namely, roots, stem bark, leaves, fruit, peels, and seeds, were harvested from a house in Ho Municipality after undergoing identification and authentication by the Institute of Traditional and Alternative Medicine, University of Health and Allied Sciences (UHAS), Ghana (Table 1). The voucher specimens were later deposited at the herbarium of the above-mentioned institution. The earth materials of these plant materials as well as undesirable materials were washed under a running tap, sliced into smaller pieces, and air-dried under shade for 7 days for leaves and 21 days for the whole stems and roots. Each dried plant part was converted into a coarse powder using an electric mill and then subjected to extraction with the appropriate solvent.

2.2. Extraction Procedure

The method of extraction was done according to the procedure described by Mills-Robertson et al. [16] with slight modifications where 70% ethanolic and hot water extractions (decoctions) were implemented to showcase the traditional style of administration of medicine. During the ethanolic extraction, 300 g of each of the coarse powders of the various above-mentioned parts with 200 g of peels and seeds was cold macerated in a proportion of 1 : 10 (W/V) of 70% ethanol at room temperature for a day. Likewise, for the hot water extraction, 300 g of each of the course powders of the test samples with 200 g of each of the peels and seeds was soaked in the various proportions of distilled water as stated above for 30 min and immediately subjected to boiling for 30 min. These preparations were then left to simmer at 60°C for 30 min and further cool at room temperature. Subsequently, the extracted solutions were filtered out, concentrated by employing the use of Buchi Rotavapor (R-200), and then freeze-dried. These portions were stored at 4°C in the refrigerator until use.

2.3. Phytochemical Screening

The presence of alkaloids, flavonoids, steroids, terpenoids, saponins, tannins, and glycosides was tested per the method described by Visweswari et al. [17] with slight modification. Grading of the final reaction of the secondary metabolites was done by comparing the results obtained for the plant extracts using how deep or light the colour change was. Table 2 shows a summary of the various tests that were conducted.

2.4. Test Organism

The test MRSA strain, NCTC 12493, used in this study was provided by the Biomedical Science Department (microbiology unit), University of Health and Allied Sciences, Ho, Ghana, and standardized to 0.5 McFarland for use.

2.4.1. Quantification of Biofilms Formation of the MRSA

The biofilm-forming potentials of the standard MRSA diluted to 0.5 McFarland standard in Mueller Hinton broth were employed per the protocols described by Elhadidy and Elsayyad [18] and Stepanović et al. [19] with slight modification. Briefly, 200 µL of the standardized inoculum prepared was added to 2 mL of broth in test tubes and incubated at 37°C for 24 h.

Planktonic MRSA cells were then aspirated and washed from the tubes to get rid of floating cells, subsequently dried at 25–28°C in an incubator, and stained with 2 mL of 0.1% crystal violet for 15 min after which they were washed with sterile water and dried at room temperature. The adherent MRSA biofilms on the walls of the tubes were then reconstituted with 2 mL ethanol, and the optical density of each test sample was read at 595 nm with a UV spectrophotometer (Jenway, Bibby Scientific Ltd, Stone, Staff., UK) after being blanked. The optical density (OD) of the sterile broth was subtracted from that of the MRSA biofilms formed to exclude the background absorbance. Each of the procedures was performed in triplicate. These OD values were considered as an index of bacteria adhering to the surface and forming biofilms. The tubes were examined, and the amount of biofilm formation was scored as follows: 0 = nonbiofilm formation, 1+ = moderate biofilm formation, and 2+ = strong biofilm formation. Nonbiofilm formation with OD595 is <0.5, moderate biofilm formation with OD 570 ranges from 0.5 to 2.5, and strong biofilm formation with OD570 is >2.5. Uninoculated tubes containing Mueller Hinton broth (2 mL) served as the negative control. The data were then averaged, and the standard deviation was calculated.

2.5. Antimicrobial Susceptibility Testing

The agar well diffusion method was carried out per the protocol adopted by Irshad et al. [20] with slight modification. Approximately 20–25 mL of molten Muller Hinton Agar was distributed into petri dishes and allowed to [R] set. With the help of sterile swab sticks, each of the MRSA strains at a final concentration of 1.8 × 108 CFU/mL was acquired and was applied to the agar plates. Seven wells were created in each agar plate using a cork borer (No. 3, 5 mm). Into these holes, 50 µL of 100 mg/mL of each test plant sample prepared with either sterile distilled water or 20% DMSO was introduced. Sterile autoclaved water or 20% DMSO was designated as negative control while 10 µg of tetracycline/ketoconazole was taken as a positive control.

2.5.1. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)

The MICs of the crude extracts and reference drugs (ampicillin, tetracycline, and streptomycin) against MRSA were determined with the micro broth dilution method using 96-well microtiter plates per the protocol adopted by Eloff [21] and Ayensu and Quartey [22] with slight modification. The original stock concentrations of 128 mg/ml and 256 µg/mL of each extract and antibiotics, respectively, were used to prepare well concentrations ranging from 32 to 0.25 mg/mL and 128 to 0.13 µg/mL. The sterile 96-well plates were then prepared by pipetting into each well 100 μL of double strength Mueller Hinton broth, 80 μL of varied concentrations of test extracts or antibiotics, and 20 μL of inoculums of a standardized suspension of MRSA to make a final volume of 200 μL. The plates were then subjected to incubation at 37°C for 24 h, after which the activity in each well was perceived with MTT. Briefly, 20 μL of MTT was added to each of the wells, and the results were noted after 30 min. Each experiment was conducted in triplicate. Subsequently, the minimum bactericidal concentration of each extract was deduced from the wells with the lowest concentrations having no colour change at which no growth occurs after subculturing for 24 h of incubation for MRSA carried out by Nester et al. [23].

2.6. Resistance Modulatory Studies of the Extracts

In this assay, 10 different concentrations of the wells prepared from 1000 mg/mL of stock solution of each extract of the plant parts were used as subinhibitory concentrations in conjunction with the antibiotics such that the concentrations arrived at were beneath the MICs of the antibiotics. Each well concentration was prepared such that a sole well of 200 μL contained 0.5 mg/mL of each of the extracts used. Synchronously, the concentrations within the range of 0.13–128 ug/mL of the test antibiotics were prepared from their stock solutions. The well plates were prepared by dispensing into each well 100 μL of double strength nutrient broth, 80 μL of the test plant samples (each plant extract and antibiotics), and 20 μL of the test standardized suspensions (10⁶ cells) of the test MRSA culture. The last column well (No. 12) served as a positive control, and the stocked broth in the test tube served as a negative control. Each of the labelled plates was then subjected to incubation at 37^oC for 24 h. This was followed by the addition of 20 μL of 3-(4, 5- dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (0.1% w/v) to each well and incubated at 37^°C for 30 min. The concentrations at which there was no colour change of the MTT added from yellow to purple compared to the next well concentration were noted as MICs.

2.7. Statistical Analysis

All measurements were expressed as mean ± SD of independent experiments using Microsoft Excel. Each of the tests was done in triplicate, and the average was recorded. Tukey’s HSD test was conducted for results of the test that were statistically significant between groups and were determined by one-way ANOVA.

3. Results

3.1. Phytochemical Screening

The results in Table 3 showed the presence of saponins, terpenoids, phenols, and tannins in different proportions in the ethanolic and aqueous extracts of the various parts of A. muricata except in the aqueous extracts of the seed. Alkaloids were as well moderately noted in all different types of the extracts of the various parts except the aqueous extracts of the leaf, peel, and stem as well as noted in the ethanol peel extract. There was an absence of steroids in the various extracts of A. muricata except being temperately observed in the aqueous and ethanolic extracts of the root.

3.2. Biofilm-Forming Capacity

The results in Table 4 indicate that the MRSA produced a moderate amount of biofilm which may be partly responsible for its resistance.

3.3. Antimicrobial Activity Determination

Each of the test extracts of A. muricata demonstrated varied antimicrobial potential against MRSA at a concentration of 100 mg/mL as shown in Figure 1 and Table 5. The stem recorded the highest inhibitory activity on MRSA for both the aqueous and the ethanolic extract, whereas the aqueous seed extract, as well as the ethanolic peel extract, demonstrated the lowest inhibitory effects.

(a)

(b)

3.4. Minimum Inhibitory Concentration

The aqueous and ethanol extracts of the plant parts tested demonstrated antimicrobial activity against the pathogenic MRSA using the broth microdilution assay. Minimum inhibitory concentrations (MICs) of the plant extracts ranged from 0.25 to 16 mg/mL (Table 6). The lesser the MIC, the better the potency of the extracts. Among the 10 extracts tested against MRSA, the ethanol root extract demonstrated the lowest MIC potential of 0.25 mg/mL, comparable to others showing varied inhibitory potential as seen in Table 6. Additionally, the results on the minimum bactericidal concentration established that each of the different extracts was bacteriostatic at varied concentrations as shown in Table 6.

3.5. Antibiotic Modulatory Activity of Various Extracts of A. muricata

From the results obtained in Table 7, it was evident that out of the 10 extracts of A. muricata, 4 of them (aqueous extract of seed, root, peels, and stem) antagonized the activity of ampicillin against the tested MRSA by a factor of 0.5 folds and the rest potentiating the drug within 1–4 folds. Furthermore, the various test extracts significantly potentiated the efficacy of streptomycin and tetracycline against the MRSA by a range of 1–32 folds with the aqueous root extract recording the highest synergistic effect and ethanol seed extract with the least effect.

4. Discussion

The various parts of Annona muricata have been known for their ethnomedicinal properties due to the antimicrobial activity it possesses. The leaves and seeds have been extensively studied due to their traditional use. The phytochemical screening of the extract of the various parts of the plant together showed the existence of secondary metabolites, and this agrees with a previous report [24, 25]. The presence of these secondary metabolites makes pharmacological studies imperative. Over 200 bioactive compounds have been reported to be found in A. muricata, with the alkaloid being the second most predominant compound after acetogenin [14].

The comparative antimicrobial activity between the various parts of A. muricata and the standard tetracycline revealed that the extract was active or potent enough as the positive control (tetracycline). The ethanolic extract of the leaf was also comparable to tetracycline, and this agrees with a similar study where a methanolic extract of the leaf showed significant antibacterial efficacy and could compete with the standard, streptomycin [26]. However, the difference in this similar report may be attributed to the location of the plant, part of the plant used for the extraction, and the extraction method as these had been reported by Inbathamizh and Padmini [27] and Khattak [28] as some of the factors accounted for the variations.

Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by a bacterium that is resistant to many of the antibiotics used to treat ordinary Staphylococcus infections [29]; hence, the ability of the extract of A. muricata to demonstrate antimicrobial activity against MRSA is quite impressive. The high MIC exhibited by the root extract of A. muricata (Table 6) suggests a decreased level of antimicrobial agents against the test organism. The combined effect of the various extracts of the plant with the standard antibiotics (streptomycin and tetracycline) showed some increase in the antimicrobial activity, and this could be attributed to the synergistic effect exhibited by their constituents.

The resistance modulation study was carried out by combining the MICs of the standard antimicrobials with subinhibitory concentrations of the various extracts of A. muricata, where the subinhibitory concentration is 1/8 of the MIC of the extract, which did not hinder the growth of microorganisms. Reduction in the MIC of the standard antimicrobials in the presence of A. muricata extract implies potentiation of activity, whereas an increase in MIC suggested antagonism in the activities of the antimicrobial agents against the test organisms. Four of the aqueous extracts of A. muricata antagonized the activity of ampicillin against the tested MRSA by a factor of 0.5 folds (Table 7). The antagonism of the activity of ampicillin may be attributed to the relation between the phytochemicals in the extract and the antibiotics. The phytoconstituents then counter chemically with antibiotics, and this may result in loss of activity [30, 31]. From the results, the combination of the aqueous extracts of the stem, root, seed, and peel with ampicillin should not be encouraged since these reduced the activity of the antibiotic.

Interestingly, due to the interaction of the various extracts with streptomycin and tetracycline, the activities of these two drugs were significantly increased against the MRSA strain used in the range of folds within 1–32 with the aqueous root extract recording the highest synergistic effect and ethanol seed extract with the least effect. This shows that the extracts contain phytochemicals that have either synergistic or inhibitory effects when combined with antibiotics. This enhances the blockade of tetracycline efflux pump activity or modification of the binding site and the biofilm inhibition recorded, which have been identified as the main mechanism of bacteria resistance to antibiotics including tetracyclines. Again, this may probably be due to the extracts’ ability to reduce efflux pump and biofilm activity, increasing drug uptake and accumulation which have been identified as the main mechanism of bacteria resistance [31, 32]. Hence, regarding this study, the underlined outcomes show the need to apply caution regarding the indiscriminate combination of herbal medicines with antibiotics to avoid bacterial resistance in most cases but to encourage correct combinations under research in helping to eradicate this menace.

5. Conclusion

The results of the present study have shown that the various extracts of A. muricata significantly potentiated the efficacy of streptomycin and tetracycline against MRSA. The aqueous root extract recorded the highest synergistic effect and ethanol seed extract with the least effect. It was observed that the combination of the aqueous extracts of the stem, root, seed, and peel with ampicillin should not be encouraged since these reduced the activity of the antibiotic. It is, therefore, recommended that further studies could be carried out to identify the phytoconstituents responsible for the observed potentiation or antagonism.

Data Availability

All the data are available within the manuscript.

Conflicts of Interest

The authors declare no conflicts of interest.

References

S. B. Levy and B. Marshall, “Antibacterial resistance worldwide: causes, challenges and responses REVIEW,” Nature Medicine, vol. 10, no. 12, pp. 122–129, 2004.
View at: Publisher Site | Google Scholar
S. B. Jones, “Cancer in the developing world: a call to action,” BMJ (Clinical research ed.), vol. 319, no. 505, pp. 505–508, 1999.
View at: Publisher Site | Google Scholar
J. A. Ainsa and B. Stuart Levy, “The antibiotic paradox. How the misuse of antibiotics destroys their curative powers, 2nd edn,” International Microbiology, vol. 5, no. 3, pp. 155-156, 2002.
View at: Publisher Site | Google Scholar
M. Ginovyan and A. Trchounian, “Novel approach to combat antibiotic resistance: evaluation of some Armenian herb crude extracts for their antibiotic modulatory and antiviral properties,” Journal of Applied Microbiology, vol. 127, no. 2, pp. 472–480, 2019.
View at: Publisher Site | Google Scholar
C. L. Ventola, “The antibiotic resistance crisis: part 1: causes and threats,” P & T: A Peer-Reviewed Journal for Formulary Management, vol. 40, no. 4, pp. 277–283, 2015.
View at: Google Scholar
WHO, Report on Antimicrobial Resistance-A Global Epidemic, World Health Organization, Geneva, Switzerland, 2010.
L. Clontz, “Biofilm inhibition: the use of a marine alkaloid derivative in the prevention of clinically-relevant biofilms,” Journal of Microbiology and Experimentation, vol. 6, no. 5, pp. 206–214, 2018.
View at: Publisher Site | Google Scholar
E. B. A. Adusei, R. K. Adosraku, J. Oppong-Kyekyeku, C. D. K. Amengor, and Y. Jibira, “Resistance modulation action, time-kill kinetics assay, and inhibition of biofilm formation effects of plumbagin from Plumbago zeylanica Linn,” Journal of Tropical Medicine, vol. 2019, Article ID 1250645, 8 pages, 2019.
View at: Publisher Site | Google Scholar
F. G. Figueredo, E. O. Ferreira, B. F. F. Lucena et al., “Modulation of the antibiotic activity by extracts from amburana cearensis A. C. Smith and anadenanthera macrocarpa (Benth.) Brenan,” BioMed Research International, vol. 23, no. 1, pp. 34–38, 2013.
View at: Google Scholar
M. S. Jabir, Y. M. Saleh, G. M. Sulaiman et al., “Green synthesis of silver nanoparticles using Annona muricata extract as an inducer of apoptosis in cancer cells and inhibitor for NLRP3 inflammasome via enhanced autophagy,” Nanomaterials, vol. 11, no. 2, p. 384, 2021.
View at: Publisher Site | Google Scholar
D. Wilson, P. Nash, H. Buttar et al., “The role of food antioxidants, benefits of functional foods, and influence of feeding habits on the Health of the older person: an overview,” Antioxidants, vol. 6, no. 4, p. 81, 2017.
View at: Publisher Site | Google Scholar
Y. Gavamukulya, F. Wamunyokoli, and H. A. El-Shemy, “Annona muricata: is the natural therapy to most disease conditions including cancer growing in our backyard? A systematic review of its research history and future prospects,” Asian Pacific Journal of Tropical Medicine, vol. 10, no. 9, pp. 835–848, 2017.
View at: Publisher Site | Google Scholar
C. Vijayameena, G. Subhashini, M. Loganayagi, and B. Ramesh, “Original Research Article Phytochemical screening and assessment of antibacterial activity for the bioactive compounds in Annona muricata,” International Journal of Current Microbiology and Applied Chemistry, vol. 2, pp. 1–8, 2013.
View at: Google Scholar
A. V. Coria-Téllez, E. Montalvo-Gónzalez, E. M. Yahia, and E. N. Obledo-Vázquez, “Annona muricata: a comprehensive review on its traditional medicinal uses, phytochemicals, pharmacological activities, mechanisms of action and toxicity,” Arabian Journal of Chemistry, vol. 11, no. 5, pp. 662–691, 2018.
View at: Publisher Site | Google Scholar
N. O. Acésio, G. S. Carrijo, T. H. Batista et al., “Assessment of the antioxidant, cytotoxic, and genotoxic potential of the Annona muricata leaves and their influence on genomic stability,” Journal of Toxicology and Environmental Health Part A, vol. 80, no. 23–24, pp. 1290–1300, 2017.
View at: Publisher Site | Google Scholar
F. C. Mills-Robertson, C. I. Onyeka, S. Crowther, K. Tay, and W. Walana, “In Vitro antimicrobial activity of “Antibact,” an herbal medicinal product against standard and clinical bacterial isolates,” Annals of Clinical Microbiology and Antimicrobials, vol. 9, no. 11, pp. 370–378, 2015.
View at: Google Scholar
G. Visweswari, R. Christopher, and W. Rajendra, “Phytochemical screening of active secondary metabolites present in Withania somnifera root: role in traditional medicine,” International Journal of pharmaceutical science and research, vol. 90, p. 24, 2015.
View at: Google Scholar
M. Elhadidy and A. Elsayyad, “Uncommitted role of enterococcal surface protein, Esp, and origin of isolates on biofilm production by Enterococcus faecalis isolated from bovine mastitis,” Journal of Microbiology, Immunology and Infection, vol. 46, no. 2, pp. 80–84, 2013.
View at: Publisher Site | Google Scholar
S. Stepanović, D. Vuković, V. Hola et al., “Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci,” Apmis, vol. 115, no. 8, pp. 891–899, 2007.
View at: Google Scholar
M. Irshad, S. Aziz, M. Shahid, N. Ahmed, F. A. Minhas, and T. Sherazi, “Antioxidant and antimicrobial activities of essential oil of Skimmea laureola growing wild in the State of Jammu and Kashmir,” vol. 6, no. 9, pp. 1680–1684, 2012.
View at: Publisher Site | Google Scholar
J. N. Eloff, “A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria,” Planta Medica, vol. 64, no. 8, pp. 711–713, 1998.
View at: Publisher Site | Google Scholar
I. Ayensu and A. K. Quartey, “Phytochemical screening and in-vitro antioxidant properties of the stem bark of Trichilia tessemannii (Harms)(Meliaceae),” World Journal of Pharmacy & Pharmaceutical Sciences, vol. 4, no. 3, pp. 76–90, 2015.
View at: Google Scholar
E. W. Nester, D. G. Anderson, C. E. Jr Roberts, N. N. Pearsall, T. Nester, and D. Hurley, Microbiology: A Human Perspective, MacGraw-Hill, New York, NY, USA, Fourth edition, 2004.
J. A. O. Olugbuyiro, O. E. Omotosho, O. S. Taiwo et al., “Antimicrobial activities and phytochemical properties of Annona muricata leaf,” Covenant Journal of Physical and Life Sciences, vol. 5, no. 2, pp. 40–49, 2018.
View at: Google Scholar
B. M. Pai, “Anti-microbial efficacy of soursop leaf extract (Annona muricata) on oral pathogens: an in-vitro study,” Journal of Clinical and Diagnostic Research, vol. 10, no. 11, 2016.
View at: Publisher Site | Google Scholar
G. O. Solomon-Wisdom, S. C. Ugoh, and B. Mohammed, “Phytochemical screening and antimicrobial activities of Annona muricata (L) leaf extract,” American Journal of Biological, Chemical and Pharmaceutical Sciences, vol. 2, no. 1, pp. 1–7, 2014.
View at: Google Scholar
L. Inbathamizh and E. Padmini, “Effect of geographical properties on the phytochemical composition and antioxidant potential of Moringa oleifera flowers,” Journal of Pharmacy Research solutions BioMedRx, vol. 1, no. 3, pp. 239–247, 2013.
View at: Google Scholar
K. F. Khattak and T. R Rahman, “Effect of geographical distributions on the nutrient composition, phytochemical profile and antioxidant activity of Morus nigra,” Pakistan journal of pharmaceutical sciences, vol. 28, no. 5, pp. 1671–1678, 2015.
View at: Google Scholar
R. A. Dickson, P. J. Houghton, P. J. Hylands, and S. Gibbons, “Antimicrobial, resistance-modifying effects, antioxidant and free radical scavenging activities ofMezoneuron benthamianum Baill.,Securinega virosa Roxb. &Wlld. andMicroglossa pyrifolia Lam,” Phytotherapy Research, vol. 20, no. 1, pp. 41–45, 2006.
View at: Publisher Site | Google Scholar
S. O. Dapaah, C. Agyare, Y. D. Boakye, and T. Appiah, “Modulatory effects of Hilleria latifolia and Laportea ovalifolia on activity of selected antibiotics,” Journal of Medicinal Plants Research, vol. 10, no. 25, pp. 360–366, 2016.
View at: Google Scholar
J. G. Costa, E. M. Nascimento, A. R. Campos, and F. F. Rodrigues, “Antibacterial activity of Momordica charantia (Curcubitaceae) extracts and fractions,” Journal of Basic and Clinical Pharmacy, vol. 2, no. 1, pp. 45–51, 2010.
View at: Google Scholar
J. M. Munita and C. A. Arias, “Mechanisms of antibiotic resistance,” Virulence Mechanisms of Bacterial Pathogens, vol. 4, no. 2, pp. 481–511, 2016.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2021 David Neglo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

922

Downloads

710

Citations